{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:13:55Z","timestamp":1790187235247,"version":"4.1.0"},"reference-count":41,"publisher":"The Society for Free Radical Research Japan","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Biochem. Nutr."],"published-print":{"date-parts":[[2018]]},"DOI":"10.3164\/jcbn.17-76","type":"journal-article","created":{"date-parts":[[2018,1,26]],"date-time":"2018-01-26T17:22:50Z","timestamp":1516987370000},"page":"270-276","source":"Crossref","is-referenced-by-count":16,"title":["The TPH1 rs211105 gene polymorphism affects abdominal symptoms and quality of life of diarrhea-predominant irritable bowel syndrome"],"prefix":"10.3164","volume":"62","author":[{"given":"Ryo","family":"Katsumata","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Kawasaki Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Shiotani","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Kawasaki Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Murao","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Kawasaki Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Ishii","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Kawasaki Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Fujita","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Kawasaki Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Kawasaki Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Haruma","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine 2, Kawasaki Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1739","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Drossman DA. Functional gastrointestinal disorders: history, pathophysiology, clinical features and Rome IV. Gastroenterology 2016; 150: 1262\u20131279.","DOI":"10.1053\/j.gastro.2016.02.032"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Enck P, Aziz Q, Barbara G, et al. Irritable bowel syndrome. Nat Rev Dis Primers 2016; 2: 16014.","DOI":"10.1038\/nrdp.2016.14"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Gralnek IM, Hays RD, Kilbourne A, Naliboff B, Mayer EA. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 2000; 119: 654\u2013660.","DOI":"10.1053\/gast.2000.16484"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Singh P, Staller K, Barshop K, et al. Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation. World J Gastroenterol 2015; 21: 8103\u20138109.","DOI":"10.3748\/wjg.v21.i26.8103"},{"key":"5","unstructured":"5 Buono JL, Mathur K, Averitt AJ, Andrae DA. Economic burden of irritable bowel syndrome with diarrhea: retrospective analysis of a U.S. commercially insured population. J Manag Care Spec Pharm 2017; 23: 453\u2013460."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Saha L. Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicine. World J Gastroenterol 2014; 20: 6759\u20136773.","DOI":"10.3748\/wjg.v20.i22.6759"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Makker J, Chilimuri S, Bella JN. Genetic epidemiology of irritable bowel syndrome. World J Gastroenterol 2015; 21: 11353\u201311361.","DOI":"10.3748\/wjg.v21.i40.11353"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Beyder A, Mazzone A, Strege PR, et al. Loss-of-function of the voltage-gated sodium channel NaV1.5 (channelopathies) in patients with irritable bowel syndrome. Gastroenterology 2014; 146: 1659\u20131668.","DOI":"10.1053\/j.gastro.2014.02.054"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Ek WE, Reznichenko A, Ripke S, et al. Exploring the genetics of irritable bowel syndrome: a GWA study in the general population and replication in multinational case-control cohorts. Gut 2015; 64: 1774\u20131782.","DOI":"10.1136\/gutjnl-2014-307997"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Gershon MD, Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 2007; 132: 397\u2013414.","DOI":"10.1053\/j.gastro.2006.11.002"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Wade PR, Chen J, Jaffe B, Kassem IS, Blakely RD, Gershon MD. Localization and function of a 5-HT transporter in crypt epithelia of the gastrointestinal tract. J Neurosci 1996; 16: 2352\u20132364.","DOI":"10.1523\/JNEUROSCI.16-07-02352.1996"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Lesch KP, Balling U, Gross J, et al. Organization of the human serotonin transporter gene. J Neural Transm Gen Sect 1994; 95: 157\u2013162.","DOI":"10.1007\/BF01276434"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Pata C, Erdal ME, Derici E, Yazar A, Kanik A, Ulu O. Serotonin transporter gene polymorphism in irritable bowel syndrome. Am J Gastroenterol 2002; 97: 1780\u20131784.","DOI":"10.1111\/j.1572-0241.2002.05841.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Yeo A, Boyd P, Lumsden S, et al. Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women. Gut 2004; 53: 1452\u20131458.","DOI":"10.1136\/gut.2003.035451"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Caspi A, Sugden K, Moffitt TE, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003; 301: 386\u2013389.","DOI":"10.1126\/science.1083968"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Walther DJ, Bader M. A unique central tryptophan hydroxylase isoform. Biochem Pharmacol 2003; 66: 1673\u20131680.","DOI":"10.1016\/S0006-2952(03)00556-2"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Li Z, Chalazonitis A, Huang YY, et al. Essential roles of enteric neuronal serotonin in gastrointestinal motility and the development\/survival of enteric dopaminergic neurons. J Neurosci 2011; 31: 8998\u20139009.","DOI":"10.1523\/JNEUROSCI.6684-10.2011"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Brown PM, Drossman DA, Wood AJ, et al. The tryptophan hydroxylase inhibitor LX1031 shows clinical benefit in patients with nonconstipating irritable bowel syndrome. Gastroenterology 2011; 141: 507\u2013516.","DOI":"10.1053\/j.gastro.2011.05.005"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Gizatullin R, Zaboli G, J\u00f6nsson EG, Asberg M, Leopardi R. Haplotype analysis reveals tryptophan hydroxylase (TPH) 1 gene variants associated with major depression. Biol Psychiatry 2006; 59: 295\u2013300.","DOI":"10.1016\/j.biopsych.2005.07.034"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Jun S, Kohen R, Cain KC, Jarrett ME, Heitkemper MM. Associations of tryptophan hydroxylase gene polymorphisms with irritable bowel syndrome. Neurogastroenterol Motil 2011; 23: 233\u2013239.","DOI":"10.1111\/j.1365-2982.2010.01623.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006; 130: 1480\u20131491.","DOI":"10.1053\/j.gastro.2005.11.061"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Andresen V, Montori VM, Keller J, West CP, Layer P, Camilleri M. Effects of 5-hydroxytryptamine (serotonin) type 3 antagonists on symptom relief and constipation in nonconstipated irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials. Clin Gastroenterol Hepatol 2008; 6: 545\u2013555.","DOI":"10.1016\/j.cgh.2007.12.015"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Fukudo S, Kaneko H, Akiho H, et al. Evidence-based clinical practice guidelines for irritable bowel syndrome. J Gastroenterol 2015; 50: 11\u201330.","DOI":"10.1007\/s00535-014-1017-0"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Shiotani A, Kusunoki H, Ishii M, et al. Pilot study of biomarkers for predicting effectiveness of ramosetron in diarrhea-predominant irritable bowel syndrome: expression of S100A10 and polymorphisms of TPH1. Neurogastroenterol Motil 2015; 27: 82\u201391.","DOI":"10.1111\/nmo.12473"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Svedlund J, Sj\u00f6din I, Dotevall G. GSRS--a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988; 33: 129\u2013134.","DOI":"10.1007\/BF01535722"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Haro H, Maekawa S, Hamada Y. Prospective analysis of clinical evaluation and self-assessment by patients after decompression surgery for degenerative lumbar canal stenosis. Spine J 2008; 8: 380\u2013384.","DOI":"10.1016\/j.spinee.2007.01.010"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Zung WW, Richards CB, Short MJ. Self-rating depression scale in an outpatient clinic. Further validation of the SDS. Arch Gen Psychiatry 1965; 13: 508\u2013515.","DOI":"10.1001\/archpsyc.1965.01730060026004"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Grasberger H, Chang L, Shih W, et al. Identification of a functional TPH1 polymorphism associated with irritable bowel syndrome bowel habit subtypes. Am J Gastroenterol 2013; 108: 1766\u20131774.","DOI":"10.1038\/ajg.2013.304"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Van Kerkhoven LA, Laheij RJ, Jansen JB. Meta-analysis: a functional polymorphism in the gene encoding for activity of the serotonin transporter protein is not associated with the irritable bowel syndrome. Aliment Pharmacol Ther 2007; 26: 979\u2013986.","DOI":"10.1111\/j.1365-2036.2007.03453.x"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Jun SE, Kohen R, Cain KC, Jarrett ME, Heitkemper MM. TPH gene polymorphisms are associated with disease perception and quality of life in women with irritable bowel syndrome. Biol Res Nurs 2014; 16: 95\u2013104.","DOI":"10.1177\/1099800412466694"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Gorard DA, Libby GW, Farthing MJ. 5-Hydroxytryptamine and human small intestinal motility: effect of inhibiting 5-hydroxytryptamine reuptake. Gut 1994; 35: 496\u2013500.","DOI":"10.1136\/gut.35.4.496"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Bearcroft CP, Andr\u00e9 EA, Farthing MJ. <i>In vivo<\/i> effects of the 5-HT3 antagonist alosetron on basal and cholera toxin-induced secretion in the human jejunum: a segmental perfusion study. Aliment Pharmacol Ther 1997; 11: 1109\u20131114.","DOI":"10.1046\/j.1365-2036.1997.d01-1389.x"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Colucci R, Gambaccini D, Ghisu N, et al. Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome. PLoS One 2013; 8: e54831.","DOI":"10.1371\/journal.pone.0054831"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Yang L, Cai H, Tou J, et al. The role of the 5-hydroxytryptamine pathway in reflux-induced esophageal mucosal injury in rats. World J Surg Oncol 2012; 10: 219.","DOI":"10.1186\/1477-7819-10-219"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Wang YM, Chang Y, Chang YY, et al. Serotonin transporter gene promoter region polymorphisms and serotonin transporter expression in the colonic mucosa of irritable bowel syndrome patients. Neurogastroenterol Motil 2012; 24: 560\u2013565.","DOI":"10.1111\/j.1365-2982.2012.01902.x"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Frank L, Kleinman L, Rentz A, Ciesla G, Kim JJ, Zacker C. Health-related quality of life associated with irritable bowel syndrome: comparison with other chronic diseases. Clin Ther 2002; 24: 675\u2013689.","DOI":"10.1016\/S0149-2918(02)85143-8"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Zhu L, Huang D, Shi L, et al. Intestinal symptoms and psychological factors jointly affect quality of life of patients with irritable bowel syndrome with diarrhea. Health Qual Life Outcomes 2015; 13: 49.","DOI":"10.1186\/s12955-015-0243-3"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Lee C, Doo E, Choi JM, et al. The increased level of depression and anxiety in irritable bowel syndrome patients compared with healthy controls: systematic review and meta-analysis. J Neurogastroenterol Motil 2017; 23: 349\u2013362.","DOI":"10.5056\/jnm16220"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Tsang SW, Auyeung KK, Bian ZX, Ko JK. Pathogenesis, experimental models and contemporary pharmacotherapy of irritable bowel syndrome: story about the brain-gut axis. Curr Neuropharmacol 2016; 14: 842\u2013856.","DOI":"10.2174\/1570159X14666160324144154"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Windgassen S, Moss-Morris R, Chilcot J, Sibelli A, Goldsmith K, Chalder T. The journey between brain and gut: a systematic review of psychological mechanisms of treatment effect in irritable bowel syndrome. Br J Health Psychol 2017; 22: 701\u2013736.","DOI":"10.1111\/bjhp.12250"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Mohammadi M, Tahmasebi Abdar H, Mollaei HR, Hajghani H, Baneshi MR, Hayatbakhsh MM. Serotonin transporter gene (SLC6A4) polymorphism and mucosal serotonin levels in southeastern iranian patients with irritable bowel syndrome. Middle East J Dig Dis 2017; 9: 26\u201332.","DOI":"10.15171\/mejdd.2016.48"}],"container-title":["Journal of Clinical Biochemistry and Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcbn\/62\/3\/62_17-76\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T17:35:06Z","timestamp":1570642506000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcbn\/62\/3\/62_17-76\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.3164\/jcbn.17-76","relation":{},"ISSN":["0912-0009","1880-5086"],"issn-type":[{"value":"0912-0009","type":"print"},{"value":"1880-5086","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}